Aventis Named to List of Top 100 Companies for Working Mothers Receives Honors Three Years Running BRIDGEWATER, N.J., Sept. 21 /PRNewswire-FirstCall/ -- For the third year in a row, Aventis has...
The sanofi-aventis Group Thanks Its Team Members and Shareholders and Launches Its New Visual Identity PARIS, Sept. 16 /PRNewswire-FirstCall/ -- The sanofi-aventis Group launched an advertising...
Aventis to Move Forward With Reissuance Process for Contested Lovenox Patent BRIDGEWATER, N.J., July 27 /PRNewswire-FirstCall/ -- Aventis announced today that it received a second rejection from...
New Data Confirm Lovenox(R) is an Effective Antithrombotic for Treatment of Acute Coronary Syndromes SYNERGY, A to Z and a Systematic Overview of Six Randomized Trials Published in JAMA...
Sanofi-Synthelabo's Offer for Aventis Expiration Date of Offers PARIS, June 23 /PRNewswire-FirstCall/ -- On June 22, 2004, the Autorite des marches financiers (AMF) -- the French stock market...
Sanofi-Synthelabo's Offer for Aventis; Adjustment of Offer Terms on Approval of Aventis Dividend PARIS, June 14 /PRNewswire-FirstCall/ -- Sanofi-Synthelabo (PARIS: SAN, NYSE: SNY) announces that...
Sanofi-Synthelabo's Offer for Aventis Expiration Date of Offers PARIS, June 1 /PRNewswire-FirstCall/ -- On June 1, 2004, the Autorite des marches financiers (AMF) -- the French stock market...
Aventis and U.S. NIH Enter Into Pandemic Influenza Vaccine Agreement World's Largest Vaccine Developer to Produce Investigational Vaccine for Clinical Trials SWIFTWATER, Pa., May 27...
Sanofi-Synthelabo's Offer for Aventis U.S. Offer Extended to Wednesday, June 30, 2004 PARIS, May 26 /PRNewswire-FirstCall/ -- Sanofi-Synthelabo (PARIS: SAN, NYSE: SNY) announces that pending the...
Data Show Once-Daily Alvesco(R) (ciclesonide) Has No Effect on HPA-Axis Function in Asthma Patients Findings Presented Suggest Minimal Potential for Adverse Effects Commonly Seen With Inhaled...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.001 | -25 | 0.004 | 0.004 | 0.003 | 282303 | 0.0030822 | DE |
4 | 0 | 0 | 0.003 | 0.004 | 0.002 | 1214996 | 0.00285603 | DE |
12 | 0.001 | 50 | 0.002 | 0.004 | 0.002 | 3172084 | 0.00323092 | DE |
26 | 0 | 0 | 0.003 | 0.004 | 0.001 | 3072997 | 0.00264066 | DE |
52 | 0 | 0 | 0.003 | 0.005 | 0.001 | 3449505 | 0.00331707 | DE |
156 | -0.011 | -78.5714285714 | 0.014 | 0.023 | 0.001 | 2275402 | 0.00556863 | DE |
260 | -0.001 | -25 | 0.004 | 0.045 | 0.001 | 2991593 | 0.01475027 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.